Trump Approval Rating Holds at Record-Low 32% in Latest Poll

Shibbir Ahmed, Washington DC — President Donald Trump’s approval rating remains at a record low in the latest Reuters/Ipsos poll, with 32% of Americans approving of his job performance and 65% disapproving as the country approaches the November midterm elections. The nationwide poll, conducted online from Sept. 30 through Oct. 5 among 4,506 U.S. adults, found Trump’s overall approval unchanged from the previous survey. The result matches the lowest approval rating recorded for Trump in the Reuters/Ipsos polling series. The poll has a margin of error of approximately two percentage points.

The findings come as voters continue to identify the cost of living and inflation as major concerns, while the administration faces political pressure over the economic effects of high energy prices and the ongoing war with Iran.

The poll found particularly low approval among Hispanic Americans. Only 24% of Hispanic respondents said they approved of Trump’s performance, the lowest level recorded for him among Hispanic voters in either of his presidential terms, according to Reuters.

The decline is notable because Hispanic voters were an important part of Trump’s coalition in the 2024 presidential election. Reuters reported that Trump received nearly half of the Hispanic vote in 2024, compared with roughly one-third in 2020. The latest findings indicate that Trump’s standing among this group has weakened considerably during his current term.

Economic issues are playing a central role in voters’ views of the administration. The Reuters/Ipsos survey found that the cost of living was the leading issue for Americans as they considered the upcoming congressional elections. Rising gasoline and diesel prices have added to concerns about household expenses.

The administration has taken several steps aimed at addressing fuel prices. On Oct. 5, Trump signed an executive order expanding access to tax-exempt diesel fuel as prices remained elevated. Reuters reported that diesel prices had reached approximately $6.50 a gallon in September. The administration has linked the energy-price pressures to disruptions caused by the war with Iran and other international supply pressures.

The Ipsos survey also measured voters’ preferences for the November 3 congressional elections. Among registered voters, 44% said they planned to support Democratic candidates, compared with 37% who said they planned to support Republican candidates. Among independent voters, Democrats held a 37%-21% advantage in the survey, while 28% of independent voters remained undecided.

Among Hispanic registered voters, 52% said they planned to support Democratic candidates, compared with 26% who said they planned to support Republicans. These figures describe the preferences of respondents at the time of the survey and do not determine the eventual election results.

Trump continues to retain substantial support within his own party, although previous Reuters/Ipsos polling has shown a decline in Republican approval.

An earlier September Reuters/Ipsos survey found that 73% of Republicans approved of Trump’s overall job performance, down from 86% in January. Republican ratings of Trump’s handling of the U.S. economy and the cost of living also declined in that survey.

The latest poll comes as Republican candidates campaign across the country ahead of the midterm elections, with economic conditions and the administration’s foreign-policy decisions becoming central campaign issues.

The latest Reuters/Ipsos findings also showed changes among older voters, a group that has historically been important in midterm elections.

Republicans held only a narrow advantage among voters aged 50 and older in the latest survey, according to Reuters. Among voters younger than 50, Democrats had a larger lead. Independent voters remained an important group because a substantial share had not decided which party they would support.

The latest polling comes amid controversy over government-funded television advertisements featuring Trump. A separate Reuters/Ipsos survey conducted during the same period found that 86% of Americans considered the use of taxpayer money for election-related television advertisements featuring the president or members of his administration inappropriate. The figure included 80% of Republicans.

The administration has said the advertisements are educational and patriotic rather than campaign material. Critics, including lawmakers from both parties, have questioned whether taxpayer funds are being used for political purposes.

With the Nov. 3 congressional elections approaching, the poll provides a snapshot of public opinion at a particularly active stage of the campaign.  Trump is not personally on the ballot, but his approval rating and the administration’s policies have become important factors in the national political environment.

Republicans currently control the White House and both chambers of Congress, making the midterm elections significant for the legislative agenda during the remaining years of Trump’s current term.

The latest Reuters/Ipsos poll shows that Americans remain focused heavily on economic pressures, particularly the cost of living, while Trump’s overall approval remains at the lowest level recorded in the Ipsos series.

The survey represents public opinion during the six-day period in which it was conducted; attitudes can change as economic conditions, international events and the election campaign develop.

 




DOJ Files 40 Denaturalization Cases Against Naturalized U.S. Citizens

Shibbir Ahmed, Washington DC— The U.S. Department of Justice has launched denaturalization proceedings against 40 naturalized U.S. citizens accused of serious crimes, immigration fraud and other conduct that the government says affected their eligibility for American citizenship.

The cases, filed in federal courts between Aug. 21 and Oct. 2, represent the largest number of denaturalization complaints filed during a single period under the Trump administration, according to the Justice Department.

The department said the cases include allegations involving foreign-government activity, espionage, violent crimes, sexual offenses, tax violations, fraudulent marriages and identity or immigration fraud.

The announcement is part of a broader Justice Department effort to pursue denaturalization in cases where prosecutors allege that citizenship was obtained illegally or through the concealment of material information.

Despite the wording sometimes used to describe the cases, the 40 individuals have not automatically lost their U.S. citizenship. The Justice Department has filed civil actions asking federal courts to revoke their naturalization. Under the Immigration and Nationality Act, naturalized citizenship can be revoked if the government establishes that it was illegally obtained or secured through concealment of a material fact or willful misrepresentation.

The cases remain subject to judicial proceedings. The allegations contained in the complaints are not, by themselves, final findings of wrongdoing. The Justice Department said the 40 cases involve a broad range of alleged offenses.

Among those identified by the department are individuals accused of concealing criminal histories during the naturalization process, using false identities or immigration documents, entering fraudulent marriages and failing to disclose information that prosecutors say was relevant to their eligibility for citizenship. The cases also include allegations involving serious criminal conduct.

One defendant, according to the department, is former U.S. Navy sailor Jinchao Wei, who was convicted of espionage and sentenced to more than 16 years in prison. The Justice Department is seeking his denaturalization based on allegations concerning his conduct and the information allegedly concealed during the citizenship process.

Another case involves Ping Li, whom the department alleges conspired to act as an agent of the Chinese government without notifying the U.S. attorney general. The department says Li was sentenced in 2024. Other cases involve alleged sexual offenses, money laundering, tax evasion, voluntary manslaughter and immigration-related fraud.

The complaints were filed across federal judicial districts throughout the United States. The individuals named in the cases come from numerous countries, including Mexico, Pakistan, China, Afghanistan, Egypt, Nigeria, Iran, Haiti, Nepal, the Philippines, Venezuela, Ghana, Cameroon, Canada, Colombia, Cambodia, Peru, Sierra Leone and the United Kingdom. One individual’s country of origin was listed as unknown.

The Justice Department said the cases are focused on allegations that the individuals obtained naturalization through unlawful means or concealed information that could have affected their eligibility.

The latest cases follow a series of denaturalization actions announced by the Justice Department during 2026. In August, the department announced 25 denaturalization complaints involving naturalized citizens accused of offenses including attempted murder, assault and sexual crimes against children. The department said at the time that the complaints filed since Jan. 20, 2025, brought its total to 123 civil denaturalization complaints, which it described as the highest number in recorded history.

The latest 40-case filing represents a further expansion of the administration’s use of denaturalization proceedings. Attorney General Todd Blanche said the department intends to continue using the process in cases where it believes citizenship was obtained through deception or unlawful conduct.

Denaturalization is a legal process through which the government seeks to cancel the citizenship of a person who became a U.S. citizen through naturalization. It is different from deportation and does not apply to people who are U.S. citizens by birth in the same way. For a naturalized citizen, the government must pursue the matter through the courts and establish the legal grounds for revocation.

The Supreme Court has also emphasized the significance of citizenship and the government’s burden when seeking to revoke naturalization. Consequently, the filing of a complaint is the beginning of a legal proceeding, not a final decision that citizenship has been revoked.

The expansion of denaturalization proceedings has drawn national attention because citizenship is a fundamental legal status carrying important constitutional and statutory rights.

The Justice Department argues that the process is necessary when individuals allegedly obtained citizenship through fraud or by concealing serious misconduct.

Civil liberties and immigration advocates, meanwhile, have raised broader concerns about the government’s increasing use of a rarely invoked legal mechanism. Coverage of the latest filings has characterized the effort as a significant expansion of denaturalization under the Trump administration.

The cases will now proceed through the federal courts, where the government’s allegations can be contested and judges will determine whether the legal requirements for denaturalization have been met.

The 40 defendants will have an opportunity to respond to the government’s allegations in court. If the government successfully proves that an individual’s naturalization was illegally obtained or obtained through material concealment or willful misrepresentation, a federal court may revoke the person’s naturalization.

Until such proceedings are resolved, however, the filing of the cases should not be treated as a final determination that the individuals have lost their citizenship.

The Justice Department’s latest action signals that denaturalization will remain an important part of the administration’s immigration enforcement strategy, with additional cases potentially moving through federal courts in the months ahead.

 




Trump Honors 9/11 Victims and First Responders

Shibbir Ahmed, Washington DC: President Donald Trump honored the victims of the September 11, 2001, terrorist attacks and the first responders who risked their lives to save others as the United States prepares to mark the 25th anniversary of the tragedy.

Trump held a remembrance ceremony Tuesday at the Ellipse outside the White House, bringing together firefighters, police officers, first responders, Gold Star families and representatives of the Tunnel to Towers Foundation.

A 21-foot steel beam recovered from the wreckage of the World Trade Center’s South Tower was displayed during the ceremony. The beam is part of the Tunnel to Towers Foundation’s “Steel Across America” initiative, which is taking pieces of the World Trade Center to communities across the country. Trump paid tribute to the nearly 3,000 people who were killed in the attacks and reaffirmed the nation’s commitment to remembering those who lost their lives.

The president also posthumously awarded the Presidential Medal of Freedom to Welles Crowther, who helped save numerous people during the attacks and became known as the “Man in the Red Bandana.” Members of Crowther’s family accepted the nation’s highest civilian honor on his behalf.

Trump also announced that a new U.S. Coast Guard fast-response cutter would be named after Jeffrey Palazzo, a New York firefighter and Coast Guard reservist who was killed in the September 11 attacks.

The White House said Trump and Vice President JD Vance will visit sites connected to the September 11 attacks on Friday, the 25th anniversary, to honor the victims and meet with their families.

On September 11, 2001, al-Qaeda terrorists hijacked four commercial airplanes. Two planes were flown into the World Trade Center towers in New York, another struck the Pentagon, and the fourth crashed in Pennsylvania after passengers attempted to regain control of the aircraft.

Nearly 3,000 people were killed in the attacks, which profoundly changed U.S. national security policy and shaped American foreign policy for decades. The anniversary ceremony comes as the country continues to remember the victims, first responders and ordinary Americans whose actions on that day became part of the history of the United States.




Trump Announces Drug-Price Deals With 9 More Pharmaceutical Companies

Shibbir Ahmed, WASHINGTON DC — President Donald Trump on Monday announced new agreements with nine pharmaceutical manufacturers aimed at lowering prescription drug prices for Americans, expanding his administration’s effort to tie U.S. drug prices to the lower prices paid in other developed countries.

The White House said the agreements bring the total number of pharmaceutical manufacturers participating in the administration’s Most-Favored-Nation (MFN) drug-pricing program to 26, covering about 89% of the branded-drug market.

The nine companies joining the latest agreements are Alcon, Astellas Pharma, BeOne Medicines, BridgeBio, CSL, Kyowa Kirin, Sun Pharma, Teva Pharmaceuticals and UCB.

Under the agreements, the companies will provide MFN pricing to state Medicaid programs across the United States on eligible medicines. The White House said the deals cover drugs used to treat a range of serious and chronic conditions, including hemophilia, Parkinson’s disease, macular degeneration, glaucoma, liver disease, skin conditions and cancer.

The administration’s MFN strategy seeks to align prices paid in the United States with the lowest prices paid by comparable developed nations.

$19.6 Billion U.S. Manufacturing Investment

The new agreements also include commitments to strengthen pharmaceutical manufacturing in the United States. According to the White House, the nine companies have collectively committed to invest at least $19.6 billion in U.S. manufacturing in the near term.

Several companies have additionally agreed to provide active pharmaceutical ingredients to the federal government’s Strategic Active Pharmaceutical Ingredients Reserve, which is intended to strengthen domestic pharmaceutical supply chains and reduce dependence on foreign sources.

UCB, for example, will contribute 163 tons of levetiracetam, a drug used to control and prevent seizures. Sun Pharma will contribute supplies of the antibiotics clindamycin and doxycycline, while Teva will provide metronidazole and amlodipine. Astellas will contribute tacrolimus, an immunosuppressant used to help prevent organ rejection following transplants.

Administration Projects Major Savings

The White House says patients have already saved more than $700 million through TrumpRx, the administration’s prescription-drug discount platform, since its launch in February.

The administration also says more than 500,000 seniors have saved a combined $216 million since July through a program offering certain GLP-1 obesity medicines for $50 a month to seniors without coverage for those drugs.

The White House’s Council of Economic Advisers estimates that the administration’s broader MFN agreements could generate approximately $600 billion in savings over the next decade. That figure is an administration estimate rather than an independently verified projection.

Part of Trump’s Broader Drug-Pricing Push

Trump ordered his administration in May 2025 to pursue Most-Favored-Nation pricing for prescription medicines, seeking to bring U.S. prices closer to those paid in other developed countries.

The administration subsequently reached agreements with major pharmaceutical manufacturers, including Pfizer, AstraZeneca, Eli Lilly, Novo Nordisk, Amgen, Bristol Myers Squibb, Merck, Novartis, Sanofi and others.

Trump launched TrumpRx.gov in February 2026 as part of the administration’s effort to make lower-priced medicines available directly to American consumers through participating manufacturers and pharmacies.

Reuters reported Monday that the latest agreements include a mix of international pharmaceutical companies and smaller biotechnology firms, expanding the program beyond the large drugmakers that participated in earlier rounds.

The new agreements come as prescription-drug affordability remains a major issue for American consumers and as the Trump administration prepares for the November midterm elections.

The White House is also calling on Congress to advance what it describes as the “Great Healthcare Plan,” which the administration says would seek to lower drug prices and insurance premiums while increasing price transparency.

For Americans, the practical impact of Monday’s agreements will depend on which medicines receive the new pricing arrangements, when the lower prices take effect and how the discounts are implemented through Medicaid and participating drug programs. The White House announcement marks the latest and one of the largest expansions of Trump’s MFN drug-pricing initiative since it began in 2025.